Xvivo Perfusion (XVIPF) 8.7700 $XVIPF Organ Pre
Post# of 273254
Posted On: 09/24/2016 3:14:14 PM
Xvivo Perfusion (XVIPF) 8.7700 $XVIPF
Organ Preservation Solutions Market 2015 - Global Strategic Business Report 2014-2020: Organ Banking: Glimpse into the Future?
M2 - Thu Oct 15, 4:19AM CDT
Research and Markets (http://www.researchandmarkets.com/research/d3ql2x/organ) has announced the addition of the "Organ Preservation Solutions - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Organ Preservation Solutions in US$ Thousand. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 21 companies including many key and niche players such as - 21st Century Medicine (US) - BioLife Solutions, Inc. (US) - Claris Injectables Limited (India) - Dr. Franz K?hler Chemie GmbH (Germany) - Essential Pharmaceuticals, LLC (US) - Lifeline Scientific (US) - Preservation Solutions, Inc. (US) - XVIVO Perfusion AB (Sweden) Key Topics Covered: 1. Industry Overview 2. Market Trends And Growth Drivers 3. Product Overview 4. Recent Industry Activity 5. Focus On Select Key Players 6. Global Market Perspective Total Companies Profiled: 21 - The United States (13) - Europe (7) - - France (2) - - Germany (1) - - The United Kingdom (1) - - Rest of Europe (3) - Asia-Pacific (Excluding Japan) (1) For more information visit http://www.researchandmarkets.com/research/d3ql2x/organ
BLFS: 1.85 (+0.04)
Organ and Tissue Transplantation Markets - Global Strategic Business Report 2014-2020
M2 - Thu Oct 30, 5:56AM CDT
Research and Markets (http://www.researchandmarkets.com/research/zx4hg8/organ_and_tissue) has announced the addition of the "Organ and Tissue Transplantation - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. This report analyzes the worldwide markets for Organ and Tissue Transplantation in Number of Procedures. The global and regional markets (except the US) for 'Organ and Tissue Transplantation' in this report are analyzed by the following Product Segments Organ Tranplantation (Heart, Kidneys, Liver, Pancreas, and Lungs) The US market for 'Organ and Tissue Transplantation' in this report is analyzed by the following Product Segments: - Organ Type (Heart, Kidneys, Liver, Pancreas, Lungs, and Intestine) - Tissue Type (Cornea, Heart Valve, Skin Grafts, Vascular Grafts, Bone Marrow, and Bone Grafts), - Bone Graft Transplantation (By Graft Type: Autologous Graft, Allograft, and Other Materials; By Application Type: General Orthopedics, Spinal Fusions, and Cranio/Maxillofacial). The report profiles 24 companies including many key and niche players such as: - CryoLife, Inc - Exactech, Inc - Folio Biosciences - K?hler Chemie - LifeCell Corporation - Medtronic, Inc. - Organogenesis, Inc. - Organ Recovery Systems - Organ Transport Systems - XVIVO Perfusion AB Key Topics Covered: I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW 2. MARKET TRENDS 3. TECHNOLOGICAL INNOVATIONS 4. MAJOR ISSUES IMPACTING TRANSPLANTATION MARKET 5. PRODUCT OVERVIEW 6. ARTIFICIAL ORGANS - AN ALTERNATIVE TO SOLID ORGAN TRANSPLANTS 7. PRESERVATION SOLUTIONS & IMMUNOSUPPRESSANT DRUGS 8. REGULATORY ENVIRONMENT 9. PRODUCT DEVELOPMENT/INNOVATIONS 10. RECENT INDUSTRY ACTIVITY 11. FOCUS ON SELECT GLOBAL PLAYERS 12. GLOBAL MARKET PERSPECTIVE III. MARKET 1. THE UNITED STATES 2. CANADA 3. EUROPE 4. ASIA-PACIFIC 5. LATIN AMERICA 6. REST OF WORLD IV. COMPETITIVE LANDSCAPE Total Companies Profiled: 24 - The United States (21) - Europe (2) - - Germany (1) - - Rest of Europe (1) - Middle East (1) For more information visit http://www.researchandmarkets.com/research/zx...and_tissue
MDT: 87.71 (-0.11), EXAC: 27.87 (-0.06), CRY: 18.14 (-0.42)
Organ Preservation Solutions Market 2015 - Global Strategic Business Report 2014-2020: Organ Banking: Glimpse into the Future?
M2 - Thu Oct 15, 4:19AM CDT
Research and Markets (http://www.researchandmarkets.com/research/d3ql2x/organ) has announced the addition of the "Organ Preservation Solutions - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Organ Preservation Solutions in US$ Thousand. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 21 companies including many key and niche players such as - 21st Century Medicine (US) - BioLife Solutions, Inc. (US) - Claris Injectables Limited (India) - Dr. Franz K?hler Chemie GmbH (Germany) - Essential Pharmaceuticals, LLC (US) - Lifeline Scientific (US) - Preservation Solutions, Inc. (US) - XVIVO Perfusion AB (Sweden) Key Topics Covered: 1. Industry Overview 2. Market Trends And Growth Drivers 3. Product Overview 4. Recent Industry Activity 5. Focus On Select Key Players 6. Global Market Perspective Total Companies Profiled: 21 - The United States (13) - Europe (7) - - France (2) - - Germany (1) - - The United Kingdom (1) - - Rest of Europe (3) - Asia-Pacific (Excluding Japan) (1) For more information visit http://www.researchandmarkets.com/research/d3ql2x/organ
BLFS: 1.85 (+0.04)
Organ and Tissue Transplantation Markets - Global Strategic Business Report 2014-2020
M2 - Thu Oct 30, 5:56AM CDT
Research and Markets (http://www.researchandmarkets.com/research/zx4hg8/organ_and_tissue) has announced the addition of the "Organ and Tissue Transplantation - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. This report analyzes the worldwide markets for Organ and Tissue Transplantation in Number of Procedures. The global and regional markets (except the US) for 'Organ and Tissue Transplantation' in this report are analyzed by the following Product Segments Organ Tranplantation (Heart, Kidneys, Liver, Pancreas, and Lungs) The US market for 'Organ and Tissue Transplantation' in this report is analyzed by the following Product Segments: - Organ Type (Heart, Kidneys, Liver, Pancreas, Lungs, and Intestine) - Tissue Type (Cornea, Heart Valve, Skin Grafts, Vascular Grafts, Bone Marrow, and Bone Grafts), - Bone Graft Transplantation (By Graft Type: Autologous Graft, Allograft, and Other Materials; By Application Type: General Orthopedics, Spinal Fusions, and Cranio/Maxillofacial). The report profiles 24 companies including many key and niche players such as: - CryoLife, Inc - Exactech, Inc - Folio Biosciences - K?hler Chemie - LifeCell Corporation - Medtronic, Inc. - Organogenesis, Inc. - Organ Recovery Systems - Organ Transport Systems - XVIVO Perfusion AB Key Topics Covered: I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW 2. MARKET TRENDS 3. TECHNOLOGICAL INNOVATIONS 4. MAJOR ISSUES IMPACTING TRANSPLANTATION MARKET 5. PRODUCT OVERVIEW 6. ARTIFICIAL ORGANS - AN ALTERNATIVE TO SOLID ORGAN TRANSPLANTS 7. PRESERVATION SOLUTIONS & IMMUNOSUPPRESSANT DRUGS 8. REGULATORY ENVIRONMENT 9. PRODUCT DEVELOPMENT/INNOVATIONS 10. RECENT INDUSTRY ACTIVITY 11. FOCUS ON SELECT GLOBAL PLAYERS 12. GLOBAL MARKET PERSPECTIVE III. MARKET 1. THE UNITED STATES 2. CANADA 3. EUROPE 4. ASIA-PACIFIC 5. LATIN AMERICA 6. REST OF WORLD IV. COMPETITIVE LANDSCAPE Total Companies Profiled: 24 - The United States (21) - Europe (2) - - Germany (1) - - Rest of Europe (1) - Middle East (1) For more information visit http://www.researchandmarkets.com/research/zx...and_tissue
MDT: 87.71 (-0.11), EXAC: 27.87 (-0.06), CRY: 18.14 (-0.42)
(0)
(0)Scroll down for more posts ▼